Evidence map›Paper›PMID 37606758›Full record

ArticleSurgery today2023

Multivisceral resection for retroperitoneal liposarcoma-is it worth it? A 20-year single-center experience.

Frederico Ribeiro Teixeira, Mariana Sousa Arakaki, Helber Vidal Gadelha Lima, Fabio de Oliveira Ferreira, Carlos Augusto Metidieri Menegozzo, Eduardo Rissi Silva, Edna Frasson de Souza Montero, Toshiko Oya, Luiz Calima Lima, Eduardo Hiroshi Akaishi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Surgery today, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Frederico Ribeiro TeixeiraDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil.
Mariana Sousa ArakakiDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil.
Helber Vidal Gadelha LimaDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil. helber.vidal@hc.fm.usp.br.ORCID http://orcid.org/0000-0002-2333-2898
Fabio de Oliveira FerreiraDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil.
Carlos Augusto Metidieri MenegozzoDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil.
Eduardo Rissi SilvaDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil.
Edna Frasson de Souza MonteroDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil.
Toshiko OyaDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil.
Luiz Calima LimaSoft Tissue Sarcoma Pathologist-Cancer Institute of the State of São Paulo (ICESP), São Paulo, Brazil.
Eduardo Hiroshi AkaishiDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil.
Edivaldo Massazo UtiyamaDivisão de Clínica Cirúrgica III - Hospital das Clínicas (HCFMUSP), Instituto Central do Hospital das Clínicas da Universidade de São Paulo, 8º andar, sala 8131, Av. Dr. Enéas de Carvalho Aguiar, 255, Cerqueira César, São Paulo, SP, 05402-000, Brazil.
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRInstituto do Câncer do Estado de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSoft tissue sarcomas are rare malignant tumors. Liposarcoma constitutes the most frequent histological subtype of retroperitoneal sarcoma. The prognosis of soft tissue sarcomas depends on clinical and histologic characteristics.

objectiveEvaluate variables that may be related to the overall and local recurrence-free survival in patients with retroperitoneal liposarcoma and discuss the need for visceral resection en-bloc for tumors.

methodsA retrospective analysis was conducted of the medical records of 60 patients seen between 1997 and 2017 who underwent surgical resection of retroperitoneal liposarcoma.

resultsThe overall survival rate at 5 years of follow-up was 75.22% (95% confidence interval [CI] 0.58-0.86). The probability of a local recurrence-free survival at 5 years of follow-up was 26.04% (95% CI 0.11-0.44). The multivariate analysis showed that dedifferentiated or pleomorphic tumors and R2/fragmented resection were associated with a shorter time to recurrence. No other characteristics markedly influenced the overall survival (P > 0.05).

conclusionPatients with dedifferentiated or pleomorphic tumors and incomplete resection were associated with higher local recurrence rates than others. This study reinforces the need for complete and en-bloc resection with organs when there is clear involvement or technical surgical difficulty to maintain the tumor integrity.

Indexed as

LiposarcomaRetroperitoneal NeoplasmsSarcomaHumansNeoplasm Recurrence, LocalPrognosisRetrospective StudiesSurvival RateLiposarcomaRetroperitoneal spaceRetrospective studySurgical oncologySurvival analysis

Identifiers

PMID37606758
OpenAlexW4386047030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.